Showing 2951-2960 of 5615 results for "".
- MedStar Union Memorial Tops 1,000 Robotic Spine Procedureshttps://reachmd.com/news/medstar-union-memorial-tops-1000-robotic-spine-procedures/2486543/Key points: MedStar Union Memorial Hospital reported completing 1,000 robotic spine procedures Robotic-assisted surgery is used to improve precision, planning, and implant placement The program reflects years of investment in robotic and navig
- PCV Booster Coverage Declines After Schedule Changehttps://reachmd.com/news/pcv-booster-coverage-declines-after-schedule-change/2486508/Key Takeaways: An analysis reports a decline in PCV booster-dose coverage following the 2020 schedule change, based on national surveillance data. Greater declines were observed in more deprived areas, with widening disparities in uptake across local a
- $1.9M Initiative Supports Early-Career Lupus Researchhttps://reachmd.com/news/19m-initiative-supports-early-career-lupus-research/2486503/Key Takeaways: The announcement describes a joint Lupus Research Alliance–Rheumatology Research Foundation partnership funding round focused on early-career lupus and rheumatology research. Five named investigators and their project titles are listed,
- Digital Twin–Guided VT Ablation Shows Early Feasibilityhttps://reachmd.com/news/digital-twinguided-vt-ablation-shows-early-feasibility/2486513/Key Takeaways: A small NEJM-reported feasibility study (n=10) evaluated MRI-based “digital twin” simulations to guide VT ablation in post–myocardial infarction patients. Digital twin–derived targets were integrated into procedural navigation, with all
- SkinPen Milestone Highlights Growth in Microneedling Demandhttps://reachmd.com/news/skinpen-milestone-highlights-growth-in-microneedling-demand/2486459/Revance announced that it has distributed more than 1 million SkinPen treatment kits nationwide since January 2025, marking a milestone for the company’s microneedling portfolio. The achievement comes approximately 1 year after the launch of SkinPen Precision Elite, the latest iteration of the de
- IL-15 Blockade Plus Phototherapy Shows Promise in Vitiligohttps://reachmd.com/news/il-15-blockade-plus-phototherapy-shows-promise-in-vitiligo/2486454/Targeting IL-15 with ordesekimab in combination with narrowband ultraviolet B (nbUVB) phototherapy led to greater repigmentation in patients with non-segmental vitiligo, according to results from a randomized, placebo-controlled trial presented by Brett King, MD, PhD, at the American Academy of D
- Prurigo Nodularis Linked to Elevated Cardiovascular Risk, Expanding View of Systemic Diseasehttps://reachmd.com/news/prurigo-nodularis-linked-to-elevated-cardiovascular-risk-expanding-view-of-systemic-disease/2486416/Growing evidence indicates prurigo nodularis (PN) is associated with increased cardiovascular risk, reinforcing the disease’s systemic nature and the potential consequences of untreated inflammation, according to a talk by Shawn Kwatra, MD, at the 2026 American Academy of Dermatology Annual Meeti
- GLP-1 Receptor Agonists Show Complex, Evolving Role in Alopecia Areatahttps://reachmd.com/news/glp-1-receptor-agonists-show-complex-evolving-role-in-alopecia-areata/2486415/The emerging and sometimes contradictory relationship between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and hair disorders, particularly alopecia areata, was the subject of a talk by Natasha Atanaskova Mesinkovska, MD, PhD, at the 2026 American Academy of Dermatology (AAD) Annual Meet
- Survey Highlights Misinformation’s Growing Impact on Public Trust and Health Perceptionhttps://reachmd.com/news/survey-highlights-misinformations-growing-impact-on-public-trust-and-health-perception/2486387/A new national survey from The Harris Poll paints a complex and increasingly consequential picture of how Americans engage with health and science inf
- Maternal Antibodies and Neonatal Protection from E. coli Sepsishttps://reachmd.com/news/maternal-antibodies-neonatal-protection-e-coli-sepsis/2486378/In a recent study published in Nature, lower maternally transferred anti–E. coli antibodies at birth were observed among infants who later developed severe infection.